VeriChip Corporation Announces Sales of VeriTrace
System to Two New Jersey Counties

Monday April 20,
2009, 8:30 am EDT
Related:
DELRAY BEACH, Fla.--(BUSINESS WIRE)--VeriChip Corporation (NASDAQ:CHIP
- News) (“VeriChip”),
a provider of radio frequency identification (RFID) systems for healthcare
and patient-related needs, announced today that it has sold the VeriTrace™ system for disaster relief and emergency
management needs to Atlantic and Mercer counties in New Jersey.
Marc Poulshock, Vice President of VeriChip’s Implantable and Emergency Management
divisions, said, “These recent orders reflect the continued demand for the VeriTrace system by emergency management personnel and
medical examiners throughout the country. Since the federal government
continues to support the necessity to be prepared for potential natural
catastrophes or acts of terrorism, we will maintain our ongoing discussions
with these organizations in the U.S.
and internationally.”
The VeriTrace system was created in the
aftermath of Hurricane Katrina where it proved helpful in identifying,
tracking and accounting for the remains of victims from the hurricane. VeriTrace was used by the Federal Disaster Mortuary
Operational Response Team (DMORT) during Hurricane Katrina recovery
operations.
VeriTrace is designed to assist state and
federal agencies in the management of emergency situations and disaster
recovery using implantable
RFID technology. The VeriTrace system includes
a unique implantable RFID microchip, a VeriTrace
Bluetooth™ handheld reader, a customized Ricoh 500SE Digital Camera capable
of receiving both RFID scanned data and GPS data wirelessly, and a
Web-enabled database for gathering and storing information and images
captured during emergency response operations. This database
ensures the precise collection, storage and inventory of all data and images
related to remains and the associated evidentiary items. This also allows the
recreation of an accurate and complete reconstruction of a disaster setting,
crime scene or similar setting where recreation is necessary.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray
Beach, Florida, has developed
the VeriMed™ Health Link System for rapidly and
accurately identifying people who arrive in an emergency room and are unable
to communicate. This system uses the first human-implantable passive RFID
microchip, cleared for medical use in October 2004 by the
United States Food and Drug Administration. To complement its healthcare
division, VeriChip Corporation established VeriGreen Energy Corporation in March 2009 to focus and
invest in the clean and alternative energy sector.
For more information on VeriChip, please call
1-800-970-2447, or e-mail info@verichipcorp.com. Additional
information can be found online at www.verichipcorp.com.
Statements about VeriChip’s future
expectations, including future revenues and earnings from the sale of VeriTrace, and all other statements in this press release
other than historical facts are “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, Section 21E of the
Securities Exchange Act of 1934, and as that term is defined in the Private
Litigation Reform Act of 1995. Such forward-looking statements involve risks
and uncertainties and are subject to change at any time, and VeriChip’s actual results could differ materially from
expected results. Additional information about these and other factors that
could affect the Company’s business is set forth in the Company’s various
filings with the Securities and Exchange Commission, including those set
forth in the Company’s 10-K filed on February 12, 2009, under the caption “Risk
Factors.” The Company undertakes no obligation to update or release any
revisions to these forward-looking statements to reflect events or
circumstances after the date of this statement or to reflect the occurrence
of unanticipated events, except as required by law.
Contact:
VeriChip Corporation Allison Tomek, 561-805-8008 atomek@verichipcorp.com
harry
http://reality101blog.blogspot.com/
|